DRAP Bans 17 Substandard Auto-Disable Syringe Batches
The Drug Regulatory Authority of Pakistan has banned the sale and use of 17 batches of auto-disable syringes after laboratory testing found them below required safety standards, triggering a nationwide regulatory alert over a potentially serious public health risk. The action was reported from Islamabad as health authorities moved to stop the circulation of products that are meant to prevent syringe reuse.
According to the regulator, the affected syringes were in the 3ml to 5ml category and had been manufactured by 11 companies. DRAP said the products failed to meet the required auto-disable performance standards, meaning the devices did not properly perform the safety function that should make them unusable after a single injection.
The samples were tested by the Central Drug Laboratory and the Drug Testing Laboratory in Karachi before the batches were declared substandard. The failure of the locking or self-disable mechanism raised concerns that the syringes could potentially be reused, defeating the basic purpose of auto-disable medical devices.
DRAP warned that reuse of such syringes can expose patients to dangerous blood-borne infections. The authority specifically linked the risk to the possible spread of hepatitis and HIV, diseases that remain major public health concerns in Pakistan and are often associated with unsafe injection practices, weak infection control and poor monitoring of medical supplies.
The regulator has issued medical product alerts for all 17 batches and imposed an immediate restriction on their sale and use across the country. Provincial drug control authorities and regulatory field teams have been directed to inspect markets, identify affected stocks and ensure that the substandard products are removed from supply chains without delay.
The action also covers imported products. DRAP said three batches manufactured by two Chinese companies were among those found non-compliant, while other affected manufacturers were based in Punjab and Khyber Pakhtunkhwa. The finding indicates that both domestic and imported medical devices will remain under scrutiny as authorities expand market surveillance.
Auto-disable syringes are designed to reduce the risk of repeated use by locking after one injection. Pakistan has repeatedly faced warnings from public health experts about unsafe injections, informal medical practices and the spread of preventable infections through contaminated needles, making the quality of such devices especially important for hospitals, clinics and pharmacies.
Manufacturers, importers and distributors have been instructed to recall the affected batches immediately. The order places responsibility on the supply chain to trace remaining stock, pull it back from markets and prevent further use in clinical or informal healthcare settings.
The development is likely to increase pressure on medical device suppliers and healthcare regulators to tighten quality checks before products reach patients. It may also lead hospitals, pharmacies and clinics to review procurement records and verify whether any of the banned batches are present in their inventories.
The next phase will depend on how quickly provincial authorities can locate and seize the affected syringes. Public health officials will also need to monitor whether recalls are completed effectively, whether any enforcement action is taken against non-compliant suppliers and whether stronger testing requirements are introduced to prevent similar risks in the future.